Frequently Asked Questions for Clinicians
Answers to clinicians’ questions – ranging from how Genomind® Professional PGx ExpressTM works, to ordering, test cost, and more.
How does Genomind Professional PGx Express work?
It is a pharmacogenetic test designed to help guide clinicians treatment decisions for their patients with mental illness. It identifies patient-specific genetic markers that affects how patients may react to treatment. It is an easily administered cheek swab test that analyzes key genes, selected based on hundreds of studies showing that variations in these genes may inform treatment decisions. Genomind Professional PGx Express is used to inform treatment for : depression, anxiety, obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), bipolar disorder, post traumatic stress disorder (PTSD), autism, schizophrenia, chronic pain and substance abuse. Each report will provide the most current, science-backed information and free consultations to help clinicians navigate the connection between an individual patient’s genetic biomarkers and their implications for mental health treatment.
Watch a short overview
How do I order Genomind Professional PGx Express for a patient?
Genomind Professional PGx Express is commercially available for use by any licensed, prescribing clinician. Clinicians may order a test kit by completing our online order form or by calling us at:
Patients should discuss with their clinician whether Genomind Professional PGx Express is right for them before being tested.
How much will Genomind Professional PGx Express cost my patient?
Genomind Professional PGx Express is submitted for reimbursement to commercial and third-party payers, Medicare, and some other government programs. Genomind has also created a Patient Assistance Program for those who qualify. (US residents only). Genomind is committed to making our testing accessible for all patients. If your patient has any specific insurance, billing or financial questions or concerns, please have them contact Genomind directly at:
If you live outside of the US – Please contact us to find out how we can help
Does Medicare cover Genomind Professional PGx Express ?
Medicare reinburses for the CYP2D6 gene analysis portion of Genomind Professional PGx Express. This portion of the test is covered when the clinician is considering an intitial therapy for treatment o fdepressive disorders or re- initiation of this therapy. The patient must have a diagnosis of major depressive disorder or bipolar disorder. For additional information, please reference www.cms.gov.
How quickly will the clinician receive the test results?
The test results will be provided to the ordering clinician in approximately 3-5 business days after we have received the patient’s cheek swab sample at the lab and all paperwork has been validated. Test results are available via our simple and secure online Clinician Portal.
How does the clinician use the report?
Genomind Professional PGx Express genetic test services will quickly provide the important information in a patient’s genetic profile. In addition, new technology and free consultative services enable access to educational resources to help medical providers understand the implications of these genetic biomarkers. In analyzing 24 genes associated with mental health treatment , Genomind Professional PGx Express provides the most comprehensive mental health genetic test results available.
What recommendations will be offered?
Genomind Professional PGx Express does not make treatment recommendations. We offer information about your patient’s potential neurochemistry and drug metabolism that can help inform your treatment decisions. You can expect to see information about the specific genetic makeup of your patient based on our test. This information, along with your patient’s medical history, can help you to tailor your treatment decisions.
Can the clinician get assistance in interpreting the test results?
Yes, included with every patient test is access to Genomind’s expert staff, enabling you to consult with a Genomind physician or pharmacist to help you navigate the connection between a patients genetic biomarkers and their implications for mental health treatment. They will be able to answer any questions you may have regarding the report and specific test results. Genomind’s ‘express’ reporting and consults will enable a broader range of practitioners involved in mental health – including primary care and OB/GYN providers – to use individual genetic profiles in making their treatment decisions
Why did you choose to include the genes that you have in Genomind Professional PGx Express?
Our clinical research and development team has chosen to include a comprehensive group of key genes to make up Genomind Professional PGx Express. These genes were selected based on hundreds of studies showing that variations in these genes can inform treatment decisions in psychiatry. For a summary of the peer reviewed, published literature supporting the inclusion of these genes in our test, and also cited in every patient report, please request our Literature Summary from our Customer Service team at email@example.com.
As we enter a new age of medicine, applying genetics and understanding more of the underpinnings of illness, it is helpful to have a reliable, consistent partner like Genomind. For the last two years, we have been ordering the Genecept Assay® on new and existing patients in our clinic, and recently I commented that I feel at a disadvantage when I don’t have access to my patient’s genetic information. Although genetic testing is not diagnostic of illness it is helpful for clinicians and patients alike. Genetic testing aids in the understanding the multitude of complex factors that coexist to cause symptoms, and certainly is helpful in planning for effective treatment which helps us get patients to remission.